KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Acquisitions (2017 - 2022)

Amgen has reported Acquisitions over the past 10 years, most recently at $3.8 billion for Q4 2022.

  • Quarterly results put Acquisitions at $3.8 billion for Q4 2022, up 331.35% from a year ago — trailing twelve months through Dec 2022 was $4.7 billion (up 425.14% YoY), and the annual figure for FY2025 was $53.0 million, changed.
  • Acquisitions for Q4 2022 was $3.8 billion at Amgen, up from $890.0 million in the prior quarter.
  • Over the last five years, Acquisitions for AMGN hit a ceiling of $13.4 billion in Q4 2019 and a floor of -$197.0 million in Q1 2018.
  • Median Acquisitions over the past 4 years was $177.0 million (2019), compared with a mean of $2.6 billion.
  • Biggest five-year swings in Acquisitions: tumbled 89.47% in 2018 and later skyrocketed 671900.0% in 2019.
  • Amgen's Acquisitions stood at $2.0 million in 2018, then skyrocketed by 671900.0% to $13.4 billion in 2019, then plummeted by 93.38% to $890.0 million in 2021, then soared by 331.35% to $3.8 billion in 2022.
  • The last three reported values for Acquisitions were $3.8 billion (Q4 2022), $890.0 million (Q4 2021), and $13.0 million (Q3 2021) per Business Quant data.